Simultaneous determination of montelukast as sparing therapy with some inhaled corticosteroids in plasma of asthmatic patients

Journal of Pharmaceutical and Biomedical Analysis

Volumn 74, Issue , 2013, Pages 250-256

  Ahmed, Sameh ^a,b   Atia, Noha N ^b  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

^b Assiut University   (Egypt)

Author keywords

Beclomethasone dipropionate; Budesonide; Fluticasone propionate; Inhaled corticosteroids; Montelukast; Steroid sparing therapy

Indexed keywords

ACETONITRILE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; CORTICOSTEROID; FLUTICASONE PROPIONATE; MONTELUKAST; PHOSPHATE BUFFERED SALINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; DRUG DETERMINATION; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; PRIORITY JOURNAL;

ACETATES; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUINOLINES;

EID: 84871813773     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.11.004     Document Type: Article

References (32)

1. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the gina dissemination committee report. Allergy 2004, 59:469-478.
2. Nagai H. Recent research and developmental strategy of anti-asthma drugs. Pharmacol. Ther. 2012, 133:70-78.
3. Hanania N.A., Chapman K.R., Kesten S. Adverse effects of inhaled corticosteroids. Am. J. Med. 1995, 98:196-208.
4. Jarvis B., Markham A. Montelukast: a review of its therapeutic potential in persistent asthma. Drugs 2000, 59:891-928.
5. Laviolette M., Malmstrom K., Lu S. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/beclomethasone additivity group. Am. J. Respir. Crit. Care Med. 1999, 160:1862-1868.
6. Alsarra I. Development of a stability-indicating HPLC method for the determination of montelukast in tablets and human plasma and its applications to pharmacokinetic and stability studies. Saudi Pharm. J. 2004, 12:136-143.
7. Ochiai H., Uchiyama N., Takano T., Hara K., Kamei T. Determination of montelukast sodium in human plasma by column-switching high performance liquid chromatography with fluorescence detection. J. Chromatogr. B 1998, 713:409-414.
8. Kitchen C.J., Wang A.Q., Musson D.G., Yang A.Y., Fisher A.L. A semiautomated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection. J. Pharm. Biomed. Anal. 2003, 31:647-654.
9. Al-Rawithi S., Al-Gazlan S., Al-Ahmadi W.W., Alshowaier I.A., Yusuf A., Raines D.A. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-sample of plasma. J. Chromtogr. B 2004, 754:527-531.
10. Chauhan B., Rani S., Nivsarkar M., Padh H. A new liquid-liquid extraction method for determination of montelukast in small volume human plasma samples using HPLC with fluorescence detector. Indian J. Pharm. Sci. 2006, 68:517-520.
11. Patel N.K., Hiten Shah G.S., Kundlik M., Sanyal M., Shrivastav P.S. Rapid determination of montelukast in human plasma by LC-ESI-MS/MS and its application to a bioequivalence study. Anal. Lett. 2009, 42:2041-2059.
12. Bharathi D.V., Hotha K.K., Jagadeesh B., Mullangi R., Naidu A. Quantification of montelukast, a selective cysteinyl leukotriene receptor (CysLT1) antagonist in human plasma by liquid chromatography-mass spectrometry: validation and its application to a human pharmacokinetic study. Biomed. Chromatogr. 2009, 23:804-810.
13. Challa B.R., Awen B.Z., Chandu B.R., Khagga M., Kotthapalli C.B. Method development and validation of montelukast in human plasma by HPLC coupled with ESI-MS/MS: application to a bioequivalence study. Sci. Pharm. 2010, 78:411-422.
14. Cheng H., Leff J.A., Amin R., Gertz B.J., De Smet M., Noonan N., Rogers J.D., Malbecq W., Meisner D., Somers G. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm. Res. 1996, 13:445-454.
15. Liu L., Cheng H., Zhao J.J., Rogers J.D. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J. Pharm. Biomed. Anal. 1997, 15:631-638.
16. Smith G.A., Rawls C.M., Kunka R.L. An automated method for the determination of montelukast in human plasma using dual-column HPLC analysis and peak height summation of the parent compound and its photodegradation product. Pharm. Res. 2004, 1:1539-1544.
17. Laugher L., Noctor T.G., Barrow A., Oxford J.M., Phillips T. An improved method for the determination of fluticasone propionate in human plasma. J. Pharm. Biomed. Anal. 1999, 21:749-758.
18. Byrro R.M., César I.C., de Santana S., Cardoso F., Mundim I.M., Teixeira S., Bonfim R.R., Gomes S.A., Pianetti G.A. A rapid and sensitive HPLC-APCI-MS/MS method determination of fluticasone in human plasma: application for a bioequivalence study in nasal spray formulations. J. Pharm. Biomed. Anal. 2012, 61:38-43.
19. Li Y.N., Tattam B.N., Brown K.F., Seale J.P. A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry. J. Pharm. Biomed. Anal. 1997, 16:447-452.
20. Derendorf H., Munzel U., Petzold U., Maus J., Mascher H., Hermann R., Bousquet J. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP 29-02, a novel aqueous nasal spray. Brit. J. Clin. Pharm. 2012, 74:125-133.
21. Carter S.J., Cápka V.H. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations. J. Chromatogr. B 2008, 76:163-169.
22. Taylor R.L., Grebe S.K., Singh R.J. Quantitative highly sensitive liquid chromatography tandem mass spectrometry method for detection of synthetic corticosteroids. Clin. Chem. 2004, 50:2345-2352.
23. Krishnaswami S., Möllmann H., Derendorf H., Hochhaus G. A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma. J. Pharm. Biomed. Anal. 2000, 22:123-212.
24. Borges N.C.D.C., Astigarraga R.B., Sverdloff C.E., Borges B.C., Paiva T.R., Galvinas P.R., Moreno R.A. Budesonide quantification by HPLC coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry. Application to a comparative systemic bioavailability of two budesonide formulations in healthy volunteers. J. Chromatogr. B 2011, 879:236-242.
25. Qu J., Qu Y., Straubinger R.M. Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 2007, 79:3786-3793.
26. Wang Y., Tang Y., Moellmann H., Hochhaus G. Simultaneous quantification of budesonide and its two metabolites, 6-beta-hydroxybudesonide and 16-alpha-hydroxyprednisolone, in human plasma by liquid chromatography negative electrospray ionization tandem mass spectrometry. Biomed. Chromatogr. 2003, 17:158-164.
27. Zou J.J., Dai L., Ding L., Xiao D.W., Bin Z.Y., Fan H.W., Liu L., Wang G.J. Determination of betamethasone and betamethasone 17-monopropionate in human plasma by liquid chromatography-positive/negative electrospray ionization tandem mass spectrometry. J. Chromatogr. B 2008, 73:159-164.
28. Tanaka N., Kobayashi H., Nakanoshi K., Minakuchi H., Ishizuka N. Monolithic LC columns: a new type of chromatographic support could lead to higher separation efficiencies. Anal. Chem. 2001, 73:420A-429A.
29. US-Food Drug Administration Guidance for Industry: Bioanalytical Method Validation 2001, Center for Drug Evaluation and Research, Rockville, MD. http://www.fda.gov/cder/guidance/4252fnl.pdf.
30. Jusko W.J., Gretch M. Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab. Rev. 1976, 5:43-140.
31. Shafaati A., Zarghi A., Foroutan S., Khoddam Madadian A. Rapid and sensitive determination of montelukast in human plasma by high performance liquid chromatographic method using monolithic column: application to pharmacokinetic studies. J. Bioequiv. Availab. 2010, 2:135-138.
32. Brus R. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. Arch. Intern. Med. 1999, 159:1903-1908.